A Google-mentored service that utilises award-winning AI to track electricity usage and cost for individual home appliances and deliver the data via a smartphone app. Verv uses patented technology to gather a home's electricity data 5 million times faster than current smart meters. The information gathered can be used to identify which appliances could be switched off to reduce unnecessary energy consumption.
Verv is funded by Centrica and has sold 12k units globally to businesses such as British Gas and Dubai Electricity & Water Authority. Verv is currently trailing their technology with 6 other international energy firms, as well as a global insurance company. In addition, Verv has also received funding via 6 government grants.
days to go:
Expired
investment:
£768,420
Novai is a UK biotechnology company, developing and commercialising transformational technology in ophthalmology. The company's initial focus is on ophthalmic disorders such as glaucoma and AMD (Age-related Macular Degeneration). Novai argues that current clinical endpoints lack early disease biomarkers to objectively detect and measure cell health and response to treatment in the retina. Novai asserts that its proprietary biological marker, DARC (Detection of Apoptosis in Retinal Cells), combined with its bespoke and patented Artificial Intelligence (AI) aided algorithm, allows, for the first time in vivo, identification of cellular-level disease activity in the retina. Novai stresses that DARC can also predict disease progression, allowing for enrichment of clinical trial cohorts. The company anticipates an exit via licensing of its biomarker business to a Contract Research Organisation (CRO), an Initial Public Offering (IPO) following a successful phase 3 trial of the diagnostic platform, or trade sale to a strategic pharmaceutical company.
days to go:
Expired
investment:
£1,314,967
Genomes.io is a safe and private DNA data storage application resolving the problem of DNA data breach and exploitation. It helps the users to store, manage, promote and arrange their genomic data in order. The company is a member of Consensys Labs Tachyon II Accelerator 2019. It has also signed MOU with TenX Health VC for lead investment and board position and, it is in discussions with Pharma & Biotech co for establishing partnerships. The company is seeking funds to bring its B2B and B2C products to market.
days to go:
Expired
investment:
£1,035,370
Kandu is a platform that helps organisations running entrepreneur/innovation leadership mentoring programs to source, classify and build online mentoring teams for faster, systematic business growth. It is a B2B business selling to 60k+ global corporates, universities and accelerators. Kandu’s software makes it easy for such organisations to set up, manage and track the progress of the best in class business growth mentoring and advisory programmes. Now, Kandu is seeking investment to further enhance its product/services and create a full-time sales operation.
days to go:
Expired
investment:
£168,512
A P2P lender for short-term borrowers focused on providing affordable, flexible and ethical loans. Welendus has full FCA authorisation and there are over 18,000 users on the platform with more than 900 loans issued. Investment is sought to expand the team with new operational members and grow the service with the use of viral marketing and referrals. The company is seeking more IP applications and to develop the service with new functionalities.
days to go:
Expired
investment:
£939,104
Vendoir aims to become the go-to app for instantly sourcing and booking event vendors on-demand with ease. It intends to operate as a marketplace model and earn revenue through commission on each transaction and via premium accounts. It asserts that it is part of the London & Partners Business Growth Programme Spring Cohort 2021. The company endeavours to disrupt the £43 billion UK events market post-Covid-19 with an on-demand app. It has a waitlist of more than 1300 interested clients and has featured in Forbes. The company will use the investment to accelerate its product launch.
days to go:
Expired
investment:
£172,457
Twickets is a web platform that allows you to buy or sell tickets at face value or less. Twickets is designed to prevent music lovers from paying excessive prices by purchasing tickets from resellers to see their favourite artists or bands.
days to go:
Expired
investment:
£1,221,081
Zapaygo allows consumers to order ahead at coffee shops, food outlets, restaurants, bars, events spaces, stadiums, and many other venues, improving customer experience while increasing venue revenues. The app also has a loyalty program for its users, RewardZ. This blockchain, digital rewards token is a key offering by Zapaygo to chain and individual merchants who can redeem RewardZ Tokens. Using Zaypaygo allows venues to reduce time taking orders by 40% and increase their sales by 30%. The company has developed an innovative technology platform that has identified core venues & corporate partners in the UK as initial target markets and is ready to scale. With the funds received, the company is focused on covering customer/corporate convenience in collecting F&B (Food & Beverage) and experience growth similar to the success experienced by apps like UberEats and Deliveroo. It also aims to offer 'order to delivery' end to end services.
days to go:
Expired
investment:
£596,030
Urban is a wellness app that allows customers to book massages, beauty treatments, personal training and more at the customer's doorstep in 60 minutes. The company's practitioners are already operating in London, Paris, Manchester and Birmingham covering all aspects of wellness, from massage to mindfulness and beyond. Urban has delivered over 650,000 appointments till date, witnessed £43 million in cumulative sales value since August 2018, onboarded 3,800 partner practitioners, and saw 7,300+ reviews on Apple app store with an average rating of 4.8/5 stars. It will use the investment to drive towards Operating Expense (OpEx) profitability by the end of Q1 2021, reach EBITDA positive by the end of 2021, and scale into new markets through remote expansion.
days to go:
Expired
investment:
£5,877,517
Graphene Composites (GC) is an international startup in nanomaterials engineering development and design. It works with manufacturers to resolve technical challenges by developing breakthrough solutions or incorporating its technologies to enhance existing product performance. GC asserts that its proprietary GC Shields provides lightweight protection for individuals and within buildings such as schools. GC has come up with a unique, virucidal and germicidal 'GC Ink'. GC stresses that GC Ink has been independently tested to show 99.97% effectiveness in filters versus SARS-CoV-2 (the coronavirus that causes Covid-19) and 100% effectiveness in one minute versus Human Coronavirus OC43 and Influenza A H1N1 virus in early tests. GC was the 2020 'Platinum Award' winner in the global 'Mass Challenge' technology competition. The company will be extending its GC Shield technologies to make wind turbines more durable and use GC Ink for filters in ventilation systems while managing its Norway and US subsidiaries.
days to go:
Expired
investment:
£1,928,109
